ASX:TLXPharmaceuticals, Biotechnology & Life SciencesBiotechnology
Telix Pharmaceuticals Ltd
$14.210
Day Range
$14.070 – $14.930
52 Week Range
$8.260 – $25.870
Volume
0.00
Avg Volume (10D)
2.64M
Market Cap
$4.82B
Price Chart
Market Statistics
Open$14.210
Previous Close$14.210
Day High$14.930
Day Low$14.070
52 Week High$25.870
52 Week Low$8.260
Valuation
Market Cap4.82B
Shares Outstanding339.38M
Price to Book8.29
Trading Activity
Volume0.00
Value Traded0.00
Performance
1 Day1.26%
5 Day6.62%
13 Week13.73%
52 Week-42.00%
YTD29.46%
Technical Indicators
RSI (14)56.44
50-Day SMA$14.244
200-Day SMA$13.319
Latest News
Biotechnology
Five New Stocks For The Healthcare Sector Rotation: PME, TLX, TNE, 360, and SDR
ASX healthcare rotation heats up as PME, TLX, TNE, 360, SDR emerge—five stocks positioned to ride the sector shift amid oil, inflation and volatility.
Hot Topics
SmallCaps Weekly Wrap & New Fundie Picks
Hot Topics
Weekly Wrap: Strong Week Despite Late Fade
ASX up 4.4% for the week; strongest since Oct 2022, despite Friday fade. Magellan-Barrenjoey merger approved; Telix jumps on US regulator nod; Iran talks ahead.
ASX 200
Telix Pharmaceuticals to acquire Canadian isotope innovator ARTMS in $125.9m deal
Australian biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) is set to acquire Canadian radioisotope technology firm ARTMS Inc in a $125.9 million deal designed to boost its supply chain and production capacity. The deal will include ARTMS’ advanced cyclotron-based isotope production platform, a manufacturing plant and a stockpile of ultra-pure rare metals required for consumable target […]